Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9641 posts found.

MHRA approves first lower-carbon beclometasone inhalers for asthma

July 24, 2026 Research and Development MHRA, asthma, inhaler, lower carbon

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first pressurised metered dose inhalers (pMDIs) to use …
News

Novogenia breaks ground on personalised healthcare campus

July 23, 2026 Research and Development Novogenia, R&D, healthcare, laboratory

Novogenia AG has broken ground on a new headquarters and laboratory campus in Hallwang, Austria, designed to expand its capabilities …
News

Phase 3 trials support expanded use of Dysport for migraine prevention

July 15, 2026 Research and Development Dysport, ipsen, migraine prevention

Ipsen has reported positive topline results from its phase 3 BEOND clinical programme evaluating Dysport (abobotulinumtoxinA) for the prevention of …
News

Roche secures CE Mark for automated latent tuberculosis blood test

July 14, 2026 Research and Development Roche, tuberculosis infection

Roche has received CE Mark approval for its Elecsys IGRA TB test, an automated blood test designed to improve the …
News

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026 Research and Development ReproNovo, fertility study

ReproNovo has dosed the first participant in its phase 2 NORDIC study evaluating RPN-002, an investigational therapy designed to improve …
News

Hormone study could support blood test for endometriosis

July 8, 2026 Research and Development endometriosis

Researchers at the University of Edinburgh have identified a distinct hormone profile associated with endometriosis that could lead to the …
News

Cyllene raises €33m to advance genetic therapy for neuro-urology

July 6, 2026 Research and Development neuro-urology

Cyllene Therapeutics has raised €33m in Series C financing to support later-stage development of EG110A, an investigational genetic medicine for …
News

Mallia secures €3m to expand hormone-free hair loss products

June 30, 2026 Research and Development Mallia Innovations, hair loss

Mallia Innovations has raised €3m to support the European expansion of its hormone-free hair growth products and prepare for potential …
News

Celerion expands Swiss bioanalytical laboratory capacity

June 29, 2026 Research and Development bioanalytical laboratory

Celerion has expanded its bioanalytical laboratory in Zurich, Switzerland, to increase capacity for drug development programmes and support growing global …
News

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026 Research and Development Vedana Therapeutics, migraine therapies

Vedana Therapeutics has emerged from stealth with $46m in Series A financing to support development of a pipeline of investigational …
News

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026 Research and Development Kither Biotech, respiratory therapy

Kither Biotech has reported positive results from a phase 1 study of KIT2014, an investigational inhaled therapy being developed for …
News

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026 Research and Development mastocytosis

New data from the PIONEER study presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026 suggest …
News

Phase 2 endometriosis trial reaches recruitment milestone

June 15, 2026 Research and Development Gesynta Pharma, endometriosis

Gesynta Pharma has announced that 50% of the target enrolment has been reached in its phase 2 NOVA trial evaluating …
News

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026 Research and Development AI, Amazon Web Services (AWS), Sofinnova

Sofinnova Partners has announced a collaboration with Amazon Web Services (AWS) aimed at expanding the use of AI across life …
News

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026 Research and Development low back pain, non-opioid treatment

Germany has granted marketing authorisation to Exilby (VER-01) for the treatment of chronic low back pain with a neuropathic component, …
News
The Gateway to Local Adoption Series

Latest content

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026

Cizzle Biotechnology expands US rollout of lung cancer blood test

July 27, 2026

MHRA approves first lower-carbon beclometasone inhalers for asthma

July 24, 2026

Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide

July 23, 2026